147 related articles for article (PubMed ID: 11480765)
21. 22q11 Copy Number Variations in a Brazilian Cohort of Children with Congenital Heart Disorders.
Floriani MA; Santos AS; Diniz BL; Glaeser AB; Gazzola Zen PR; Machado Rosa RF
Mol Syndromol; 2023 Feb; 14(1):1-10. PubMed ID: 36777701
[TBL] [Abstract][Full Text] [Related]
22. The Oral Health of Patients with DiGeorge Syndrome (22q11) Microdeletion: A Case Report.
Candelo E; Estrada-Mesa MA; Jaramillo A; Martinez-Cajas CH; Osorio JC; Pachajoa H
Appl Clin Genet; 2021; 14():267-277. PubMed ID: 34103968
[TBL] [Abstract][Full Text] [Related]
23. Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
Kuo CY; Signer R; Saitta SC
Curr Allergy Asthma Rep; 2018 Oct; 18(12):75. PubMed ID: 30377837
[TBL] [Abstract][Full Text] [Related]
24. The Severity of Vestibular Dysfunction in Deafness as a Determinant of Comorbid Hyperactivity or Anxiety.
Antoine MW; Vijayakumar S; McKeehan N; Jones SM; Hébert JM
J Neurosci; 2017 May; 37(20):5144-5154. PubMed ID: 28438970
[TBL] [Abstract][Full Text] [Related]
25. Genetic Advances in the Understanding of Microtia.
Gendron C; Schwentker A; van Aalst JA
J Pediatr Genet; 2016 Dec; 5(4):189-197. PubMed ID: 27895971
[TBL] [Abstract][Full Text] [Related]
26. Two patients with small chromosome 22q11.21 alterations and central nervous system abnormalities.
Guy C; Wang X; Lu X; Lu J; Li S
Mol Cytogenet; 2015; 8():102. PubMed ID: 26719767
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular cytogenetic studies of an unrecognised 22q11.2 deletion in three families.
Huang L; Xie Y; Zhou Y; Luo Y; Huang X; Xu Z; Cai D; Fang Q
Exp Ther Med; 2015 Mar; 9(3):823-828. PubMed ID: 25667635
[TBL] [Abstract][Full Text] [Related]
28. A novel immunodeficiency syndrome associated with partial trisomy 19p13.
Seidel MG; Duerr C; Woutsas S; Schwerin-Nagel A; Sadeghi K; Neesen J; Uhrig S; Santos-Valente E; Pickl WF; Schwinger W; Urban C; Boztug K; Förster-Waldl E
J Med Genet; 2014 Apr; 51(4):254-63. PubMed ID: 24431329
[TBL] [Abstract][Full Text] [Related]
29. Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome.
Karpinski BA; Maynard TM; Fralish MS; Nuwayhid S; Zohn IE; Moody SA; LaMantia AS
Dis Model Mech; 2014 Feb; 7(2):245-57. PubMed ID: 24357327
[TBL] [Abstract][Full Text] [Related]
30. Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial.
Wapner RJ; Driscoll DA; Simpson JL
Prenat Diagn; 2012 Apr; 32(4):396-400. PubMed ID: 22467170
[TBL] [Abstract][Full Text] [Related]
31. Head and neck manifestations of 22q11.2 deletion syndromes.
Marom T; Roth Y; Goldfarb A; Cinamon U
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):381-7. PubMed ID: 21861138
[TBL] [Abstract][Full Text] [Related]
32. Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome.
Alkalay AA; Guo T; Montagna C; Digilio MC; Dallapiccola B; Marino B; Morrow B
Am J Med Genet A; 2011 Mar; 155A(3):548-54. PubMed ID: 21337693
[TBL] [Abstract][Full Text] [Related]
33. Dicer activity in neural crest cells is essential for craniofacial organogenesis and pharyngeal arch artery morphogenesis.
Nie X; Wang Q; Jiao K
Mech Dev; 2011; 128(3-4):200-7. PubMed ID: 21256960
[TBL] [Abstract][Full Text] [Related]
34. Temporal lobe pleomorphic xanthoastrocytoma and acquired BRAF mutation in an adolescent with the constitutional 22q11.2 deletion syndrome.
Murray JC; Donahue DJ; Malik SI; Dzurik YB; Braly EZ; Dougherty MJ; Eaton KW; Biegel JA
J Neurooncol; 2011 May; 102(3):509-14. PubMed ID: 20730472
[TBL] [Abstract][Full Text] [Related]
35. Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart disease.
Tomita-Mitchell A; Mahnke DK; Larson JM; Ghanta S; Feng Y; Simpson PM; Broeckel U; Duffy K; Tweddell JS; Grossman WJ; Routes JM; Mitchell ME
Physiol Genomics; 2010 Sep; 42A(1):52-60. PubMed ID: 20551144
[TBL] [Abstract][Full Text] [Related]
36. Tbx1 regulates Vegfr3 and is required for lymphatic vessel development.
Chen L; Mupo A; Huynh T; Cioffi S; Woods M; Jin C; McKeehan W; Thompson-Snipes L; Baldini A; Illingworth E
J Cell Biol; 2010 May; 189(3):417-24. PubMed ID: 20439995
[TBL] [Abstract][Full Text] [Related]
37. Cardiac abnormalities and facial anthropometric measurements in children from the Free State and Northern Cape provinces of South Africa with chromosome 22q11.2 microdeletion.
Brown SC; Henderson BD; Buys DA; Theron M; Long MA; Smit F
Cardiovasc J Afr; 2010; 21(1):32-6. PubMed ID: 20224843
[TBL] [Abstract][Full Text] [Related]
38. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).
Jolin EM; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Apr; 11(2):99-105. PubMed ID: 19302762
[TBL] [Abstract][Full Text] [Related]
39. Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function.
Samuels IS; Karlo JC; Faruzzi AN; Pickering K; Herrup K; Sweatt JD; Saitta SC; Landreth GE
J Neurosci; 2008 Jul; 28(27):6983-95. PubMed ID: 18596172
[TBL] [Abstract][Full Text] [Related]
40. Sclerocornea associated with the chromosome 22q11.2 deletion syndrome.
Binenbaum G; McDonald-McGinn DM; Zackai EH; Walker BM; Coleman K; Mach AM; Adam M; Manning M; Alcorn DM; Zabel C; Anderson DR; Forbes BJ
Am J Med Genet A; 2008 Apr; 146A(7):904-9. PubMed ID: 18324686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
